Yahoo Finance Why Accuray Is Soaring Today
What happened
In response to its announcement of fiscal fourth-quarter and full-year results, Accuray (NASDAQ: ARAY), the maker of the CyberKnife Stereotactic Radiosurgery System, saw its shares jump as much 17% in early morning trading on Friday. Shares have since cooled off, but were still up about 6% as of 11:05 a.m. EDT.
So what
Here's a look at the headline numbers from the company's fourth quarter:
Total revenue increased 1.5% to $113.7 million. The slight jump was driven by a 15% increase in services revenue and a 10% decrease in product revenue.
Gross product orders jumped 12% to $96.4 million.
There was a net loss of $0.9 million, or $0.01 per share. For context, Wall Street was expecting a loss of $0.02, so this was a modest beat.
Cash balance at quarter end was $93 million.
Image source: Getty Images.
Zooming out to the full fiscal year, here are the key takeaways:
Revenue increased 6% to $405 million.
The backlog increased 6% to $478.5 million.
Gross margin expanded 300 basis points to 40%.
There was a net loss of $23.9 million, or $0.28 per share.
Turning to guidance, here's what management expects to happen in fiscal 2019:
Revenue is expected to land between $415 million and $425 million. The midpoint of the range is ahead of the $413 million in revenue that Wall Street had projected.
Adjusted EBITDA is expected to land between $21 million and $27 million. This represents growth of about 23% to 58% on a year-over-year basis.
Traders appear to be applauding the smaller-than-expected loss and the revenue guidance.
Now what
Accuray's stock had fallen by nearly 20% year to date before this earnings release, so today's relief rally makes sense given the better-than-expected revenue guidance. However, the midpoint of that guidance represents growth of about 4% year over year, a figure that I have a hard time getting excited about.
It's also worth pointing out that CFO Kevin Waters announced his decision to leave the company as of Oct. 1 to take a job with a privately held company. That news doesn't exactly fill me with confidence about Accuray's long-term potential.
Overall, I understand why Accuray is moving higher today, but this company doesn't come close to offering the growth potential that I like to see in an investment. For that reason, I have no interest in becoming a shareholder.
More From The Motley Fool
Brian Feroldi has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
